{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:37:11Z","timestamp":1791247031227,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014941","name":"Cytokinetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.nuclcard.2024.102122","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:08:26Z","timestamp":1747652906000},"page":"102122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["To screen or not to screen for transthyretin cardiac amyloidosis"],"prefix":"10.1016","volume":"47","author":[{"given":"Mallika","family":"Lal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Masri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevgeniy","family":"Brailovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nuclcard.2024.102122_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.nuclcard.2024.102122_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nuclcard.2024.102122_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","volume":"392","author":"Fontana","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nuclcard.2024.102122_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nuclcard.2024.102122_bib5","series-title":"CARDIO-TTRansform: a study to evaluate the efficacy and safety of eplontersen (formerly known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in participants with transthyretin-mediated amyloid cardiomyopathy (ATTR cm) | ClinicalTrials.gov [internet]","year":"2024"},{"key":"10.1016\/j.nuclcard.2024.102122_bib6","series-title":"Study of ALXN2220 versus placebo in adults with ATTR-CM | ClinicalTrials.gov [internet]","year":"2024"},{"key":"10.1016\/j.nuclcard.2024.102122_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101948","article-title":"Rationale & design of ACT-EARLY, the acoramidis transthyretin amyloidosis prevention trial: early detection using cardiac radionuclide imaging","volume":"38","author":"Soman","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib8","first-page":"1","article-title":"Screening Programmes: a short guide","volume":"1","year":"2020","journal-title":"WHO Press [Internet]"},{"key":"10.1016\/j.nuclcard.2024.102122_bib9","series-title":"United States Preventive Services Taskforce","year":"2024"},{"key":"10.1016\/j.nuclcard.2024.102122_bib10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/CIRCULATIONAHA.121.055517","article-title":"Cardiac scintigraphy and screening for transthyretin cardiac amyloidosis: caveat emptor","volume":"144","author":"Maurer","year":"2021","journal-title":"Circulation [Internet]"},{"key":"10.1016\/j.nuclcard.2024.102122_bib11","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis","volume":"13","author":"Musumeci","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40271-017-0273-5","article-title":"Light chain (AL) amyloidosis: the journey to diagnosis","volume":"11","author":"McCausland","year":"2018","journal-title":"Patient [Internet]"},{"key":"10.1016\/j.nuclcard.2024.102122_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12350-018-1307-7","article-title":"Estimating cancer risk from 99mTc pyrophosphate imaging for transthyretin cardiac amyloidosis","volume":"27","author":"Einstein","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2019.04.054","article-title":"Association of carpal tunnel syndrome with amyloidosis, heart failure, and adverse cardiovascular outcomes","volume":"74","author":"Fosb\u00f8l","year":"2019","journal-title":"J Am Coll Cardiol [Internet]"},{"key":"10.1016\/j.nuclcard.2024.102122_bib15","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamacardio.2021.3070","article-title":"Prevalence of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction","volume":"6","author":"Abouezzeddine","year":"2021","journal-title":"JAMA Cardiol [Internet]"},{"issue":"6","key":"10.1016\/j.nuclcard.2024.102122_bib16","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1002\/ehf2.14971","article-title":"Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy","volume":"11","author":"Garcia-Pavia","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.nuclcard.2024.102122_bib17","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/CIRCULATIONAHA.119.045093","article-title":"Cost-effectiveness of Tafamidis therapy for transthyretin amyloid cardiomyopathy","volume":"141","author":"Kazi","year":"2020","journal-title":"Circulation [Internet]"},{"key":"10.1016\/j.nuclcard.2024.102122_bib18","article-title":"National and regional medicare spending on Tafamidis, 2019-2021","volume":"7","author":"Blatt","year":"2024","journal-title":"JAMA Netw Open [Internet]"},{"key":"10.1016\/j.nuclcard.2024.102122_bib19","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jamacardio.2023.1525","article-title":"Age dependency of cardiovascular outcomes with the amyloidogenic pV142I transthyretin variant among black individuals in the US","volume":"8","author":"Selvaraj","year":"2023","journal-title":"JAMA Cardiol [Internet]"},{"key":"10.1016\/j.nuclcard.2024.102122_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/13506129.2018.1498782","article-title":"Seven factors predict a delayed diagnosis of cardiac amyloidosis","volume":"25","author":"Bishop","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.nuclcard.2024.102122_bib21","series-title":"Principles and practice of screening for disease","author":"Wilson","year":"2020"},{"key":"10.1016\/j.nuclcard.2024.102122_bib22","doi-asserted-by":"crossref","first-page":"i3139","DOI":"10.1136\/bmj.i3139","article-title":"The spectrum effect in tests for risk prediction, screening, and diagnosis","volume":"353","author":"Usher-Smith","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.nuclcard.2024.102122_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jeae021","article-title":"Limitations of apical sparing pattern in cardiac amyloidosis: a multicenter echocardiographic study","author":"Cotella","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib24","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","article-title":"Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis","volume":"13","author":"Pan","year":"2020","journal-title":"JACC (J Am Coll Cardiol): Cardiovascular Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020358","article-title":"Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis","volume":"10","author":"Pucci","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nuclcard.2024.102122_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024717","article-title":"Correlation between cardiac images, biomarkers, and amyloid load in wild-type transthyretin amyloid cardiomyopathy","volume":"11","author":"Morioka","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nuclcard.2024.102122_bib27","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.jacc.2020.03.019","article-title":"Myocardial interstitial fibrosis in nonischemic heart disease, Part 3\/4: JACC focus seminar","volume":"75","author":"D\u00edez","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13244-023-01506-6","article-title":"Myocardial extracellular volume quantification with computed tomography\u2014current status and future outlook","volume":"14","author":"Cundari","year":"2023","journal-title":"Insights into Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib29","first-page":"284","article-title":"Binding of serum amyloid P-component (SAP) by amyloid fibrils","volume":"38","author":"Pepys","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib30","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/eurheartj\/ehad139","article-title":"Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis","volume":"44","author":"Rauf","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nuclcard.2024.102122_bib43","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1253\/circj.CJ-23-0223","article-title":"Prevalence of cardiac amyloidosis in patients undergoing carpal tunnel release with amyloid deposition","volume":"87","author":"Takashio","year":"2023","journal-title":"Circ J"},{"key":"10.1016\/j.nuclcard.2024.102122_bib44","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2022.06.026","article-title":"Screening for cardiac amyloidosis 5 to 15 Years after surgery for bilateral carpal tunnel syndrome","volume":"80","author":"Westin","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib31","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release","volume":"72","author":"Sperry","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijcard.2020.12.044","article-title":"Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: the ACTUAL study","volume":"329","author":"Vianello","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib46","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ehf2.14173","article-title":"Identification of wild-type transthyretin cardiac amyloidosis in patients with carpal tunnel syndrome surgery (CACTuS)","volume":"10","author":"Ladefoged","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.nuclcard.2024.102122_bib47","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1253\/circrep.CR-21-0046","article-title":"Tenosynovial and cardiac transthyretin amyloidosis in Japanese patients undergoing carpal tunnel release","volume":"3","author":"Sugiura","year":"2021","journal-title":"Circ Rep"},{"key":"10.1016\/j.nuclcard.2024.102122_bib48","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/13506129.2021.1950681","article-title":"Association between spinal stenosis and wild-type ATTR amyloidosis","volume":"28","author":"Godara","year":"2021","journal-title":"Amyloid"},{"key":"10.1016\/j.nuclcard.2024.102122_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131301","article-title":"Cardiac amyloidosis in patients with spinal stenosis and yellow ligament hypertrophy","volume":"392","author":"Negreira-Caama\u00f1o","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib32","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1111\/jgs.17976","article-title":"Analysis of lumbar spine stenosis specimens for identification of amyloid","volume":"70","author":"Maurer","year":"2022","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.nuclcard.2024.102122_bib50","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jnnp-2023-332180","article-title":"Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers","volume":"95","author":"Beauvais","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nuclcard.2024.102122_bib35","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s12350-019-01950-2","article-title":"Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation","volume":"28","author":"Minutoli","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jcmg.2016.06.003","article-title":"Can 99mTc-pyrophosphate aid in early detection of cardiac involvement in asymptomatic variant TTR amyloidosis?","volume":"10","author":"Haq","year":"2017","journal-title":"JACC (J Am Coll Cardiol): Cardiovascular Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib52","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nuclcard.2024.102122_bib53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.regg.2022.10.005","article-title":"Prevalence of transthyretin cardiac amyloidosis in elderly patients diagnosed with heart failure","volume":"58","author":"Jaramillo-Hidalgo","year":"2023","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib54","doi-asserted-by":"crossref","first-page":"672","DOI":"10.33963\/KP.a2022.0098","article-title":"Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction","volume":"80","author":"Murat","year":"2022","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib55","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1002\/ehf2.13360","article-title":"Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy","volume":"8","author":"Devesa","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.nuclcard.2024.102122_bib56","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030271","article-title":"Amyloid transthyretin cardiomyopathy in elderly patients with aortic stenosis undergoing transcatheter aortic valve implantation","volume":"12","author":"Dobner","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nuclcard.2024.102122_bib57","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib58","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ejhf.1974","article-title":"Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis","volume":"23","author":"Rosenblum","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nuclcard.2024.102122_bib59","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/eurheartj\/ehaa170","article-title":"Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation","volume":"41","author":"Scully","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nuclcard.2024.102122_bib33","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/13506129.2023.2230516","article-title":"Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosis","volume":"30","author":"Marchi","year":"2023","journal-title":"Amyloid"},{"key":"10.1016\/j.nuclcard.2024.102122_bib34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004","volume":"79","author":"Gertz","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/13506129.2020.1744553","article-title":"The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease","volume":"27","author":"Azevedo Coutinho","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.nuclcard.2024.102122_bib37","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jcmg.2020.09.023","article-title":"Radionuclide imaging in the diagnosis of transthyretin cardiac amyloidosis","volume":"14","author":"Rodrigues","year":"2021","journal-title":"JACC (J Am Coll Cardiol): Cardiovascular Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028534","article-title":"Design and rationale the SCAN-MP (screening for cardiac amyloidosis with nuclear imaging in minority populations) study","volume":"12","author":"Ruberg","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nuclcard.2024.102122_bib39","article-title":"Occult transthyretin cardiac amyloid in severe calcific aortic stenosis","volume":"9","author":"Treibel","year":"2016","journal-title":"Circulation: Cardiovascular Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2967\/jnumed.106.037200","article-title":"Skeletal PET with 18F-fluoride: applying new technology to an old tracer","volume":"49","author":"Grant","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102122_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.010249","article-title":"Efficient 1-hour technetium-99 m pyrophosphate imaging protocol for the diagnosis of transthyretin cardiac amyloidosis","volume":"13","author":"Masri","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib42","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/eurheartj\/ehaa091","article-title":"Hot hearts on bone scintigraphy are not all amyloidosis: hydroxychloroquine-induced restrictive cardiomyopathy","volume":"41","author":"Layoun","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nuclcard.2024.102122_bib60","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro","year":"2018","journal-title":"Clin Med"},{"key":"10.1016\/j.nuclcard.2024.102122_bib61","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.nuclcard.2024.102122_bib62","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/CIRCULATIONAHA.122.060852","article-title":"Impact of earlier diagnosis in cardiac ATTR amyloidosis over the course of 20 years","volume":"146","author":"Ioannou","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2024.102122_bib63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40259-023-00577-7","article-title":"RNA targeting and gene editing strategies for transthyretin amyloidosis","volume":"37","author":"Ioannou","year":"2023","journal-title":"BioDrugs"},{"key":"10.1016\/j.nuclcard.2024.102122_bib64","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib65","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","article-title":"Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis","volume":"25","author":"Stats","year":"2016","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib66","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11886-022-01703-7","article-title":"Imaging-guided treatment for cardiac amyloidosis","volume":"24","author":"Ioannou","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.nuclcard.2024.102122_bib67","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/ehjci\/jeab095","article-title":"99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis","volume":"22","author":"Quarta","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib68","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCIMAGING.123.015259","article-title":"Rare forms of cardiac amyloidosis: diagnostic clues and phenotype in apo AI and AIV amyloidosis","volume":"16","author":"Ioannou","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib69","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jcmg.2022.07.008","article-title":"Multi-imaging characterization of cardiac phenotype in different types of amyloidosis","volume":"16","author":"Ioannou","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib70","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nuclcard.2024.102122_bib71","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jcmg.2023.02.019","article-title":"Tracking multiorgan treatment response in systemic AL-amyloidosis with cardiac magnetic resonance derived extracellular volume mapping","volume":"16","author":"Ioannou","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib72","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib73","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2024.102122_bib74","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.jacc.2020.04.022","article-title":"Cardiac scintigraphy with technetium-99m-labeled bone-seeking tracers for suspected amyloidosis: JACC review topic of the week","volume":"75","author":"Hanna","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib75","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102122_bib76","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.cardfail.2019.08.002","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2\u2014diagnostic criteria and appropriate utilization","volume":"25","author":"Dorbala","year":"2019","journal-title":"J Card Fail"},{"key":"10.1016\/j.nuclcard.2024.102122_bib77","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1056\/NEJM197810262991705","article-title":"Problems of spectrum and bias in evaluating the efficacy of diagnostic tests","volume":"299","author":"Ransohoff","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nuclcard.2024.102122_bib78","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007059","article-title":"Hydroxychloroquine-mediated cardiotoxicity with a false-positive 99mTechnetium-labeled pyrophosphate scan for transthyretin-related cardiac amyloidosis","volume":"11","author":"Chang","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib79","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12872-016-0311-6","article-title":"Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis","volume":"16","author":"Zhao","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.nuclcard.2024.102122_bib80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET","volume":"54","author":"Antoni","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102122_bib81","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","article-title":"[18F]-Florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions","volume":"14","author":"Genovesi","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib82","first-page":"1419","article-title":"Cardiac amyloid quantification using 124I-evuzamitide (124I-P5+14) versus 18F-florbetapir: a pilot PET\/CT study","volume":"16","author":"Clerc","year":"2023","journal-title":"Cardiovascular Imaging"},{"key":"10.1016\/j.nuclcard.2024.102122_bib83","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/CIRCULATIONAHA.118.034338","article-title":"Fully automated echocardiogram interpretation in clinical practice","volume":"138","author":"Zhang","year":"2018","journal-title":"Circulation"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358124008249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358124008249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:59:33Z","timestamp":1748001573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358124008249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":83,"alternative-id":["S1071358124008249"],"URL":"https:\/\/doi.org\/10.1016\/j.nuclcard.2024.102122","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"To screen or not to screen for transthyretin cardiac amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2024.102122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of American Society of Nuclear Cardiology.","name":"copyright","label":"Copyright"}],"article-number":"102122"}}